BUOY-XX
Live / Applied — Non-final action mailed (as of 13 Jan 2026)
What this means for you
Not registered yet, but its 29 Aug 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99365329
- Mark type
- Word mark
- Filed
- 29 Aug 2025
- Attorney of record
- Nicholas B. Hawkins
Goods and services
- Class 005 — Pharmaceuticals: Technologies in the nature of pharmaceutical preparations of drugs that facilitate the delivery of pharmaceutical compounds for oral administration of therapeutics utilizing the lymphatic system to treat human and animal disease and illness, namely infectious diseases, inflammatory disorders, respiratory diseases, cardiovascular diseases, autoimmune disorders, gastrointestinal disorders, cancer, hematological diseases, neurological diseases, neuropsychiatric disorders, hepatic diseases, renal diseases, lymphatic disorders, metabolic disorders, genetic disorders, dermatological disorders, ocular diseases, and orphan diseases
- Class 009 — Scientific and electric apparatus: Downloadable application software for accessing and managing clinical trial data
- Class 042 — Scientific and technological services: Providing access to non-downloadable software for accessing clinical trials and managing clinical trial data
Owner
- Seaport Therapeutics, Inc., Boston, MA, US
Prosecution history
- 19 Mar 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 19 Mar 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 13 Jan 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 13 Jan 2026 — NON-FINAL ACTION E-MAILED
- 13 Jan 2026 — NON-FINAL ACTION WRITTEN
- 13 Jan 2026 — ASSIGNED TO EXAMINER
- 13 Jan 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 13 Jan 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 29 Aug 2025 — APPLICATION FILING RECEIPT MAILED
- 29 Aug 2025 — NEW APPLICATION ENTERED